Purpose and clinical scope
The Spica rental service provides temporary specialist seating for patients whose postural, pressure management, mobility or functional needs require individually configured seating during a defined period of recovery, rehabilitation or clinical treatment.
The service is designed to support patients across hospital, discharge and community pathways where seating is required for a limited or uncertain period and where timely access to an appropriate seating solution is clinically important.
The service operates in conjunction with, and under the direction of, the prescribing clinical team. The prescribing clinician or clinical team retains responsibility for establishing the patient’s clinical need and prescribing the appropriate seating requirements. Our role is to translate that prescription into a safe, correctly configured and quality-assured seating solution, and to manage the equipment and associated service throughout the patient’s episode of care.
The service therefore combines specialist seating expertise with equipment provision, configuration, fitting, logistics, technical support, maintenance, recovery and infection control.
1. Referral and clinical prescription
Referral:
A referral is received from the prescribing clinical team together with the patients seating specification and relevant clinical requirements. At referral we:
The service in intended to reduce delays associated with sourcing and preparing temporary seating with maintaining a clear clinical prescribing pathway.
Clinical responsibility:
The prescribing clinical team remains responsible for the clinical prescription and determination of the patient’s seating needs.
Our specialist team is responsible for implementing the prescription, configuring the equipment, verifying its technical suitability and supporting safe use. Where information is unclear, requirements cannot be safely achieved, or the patient’s needs appear to have changed, the matter is referred back to the prescribing clinical team for review.
2. Clinical preparation and quality assurance
Before equipment leaves our facility, the chair is prepared specifically for the patient and subjected to a controlled quality assurance process. This includes:
The purpose of this stage is to ensure that the equipment arriving for the patient is configured and technically ready for clinical commissioning, reducing the need for avoidable changes at the point of delivery.
Typical resource: approximately 4 hours for preparation, QA, documentation and release to logistics, depending on equipment and patient requirements.
3. Specialist delivery, fitting and commissioning
Delivery may be undertaken by our seating specialists or through managed logistics, depending on the clinical requirements of the patient, location and the agreed pathway.
Before introducing the chair to the patient, a pre-fit review is undertaken to confirm that the equipment and configuration remain appropriate for the intended clinical use. This is particularly important for patients recovering from surgery, trauma, or other significant changes in physical function.
At the fitting and commissioning appointment the seating specialist will, as appropriate:
Appointments typically take 60–90 minutes, depending on patient complexity and the equipment provided, and may take place in hospital or at home.
The purpose of commissioning is to establish that the prescribed seating solution has been correctly configured, safely fitted and understood by those responsible for the patient’s day-to-day care.
4. Ongoing clinical and technical support
Our responsibility continues throughout the rental period rather than ending at delivery. Support may include:
Where there is a material change in the patient’s clinical presentation – for example, a change in posture, skin integrity, pain, tolerance, functional ability or other relevant clinical requirement – we do not independently redefine the patient’s clinical prescription. Instead, concerns are communicated to the prescribing clinical team so that the clinical requirement can be reviewed and, where appropriate, the prescription amended. This provides a clear distinction between clinical prescribing and technical implementation and support.
5. Managing changes in the patients pathway
Temporary seating requirements frequently change because of surgery dates, discharge arrangements, clinical appointments or changes in the patients place of care. We manage the operational consequences of these changes wherever possible, including:
This provides continuity for the patient while reducing the administrative and logistical burden on clinical teams. Where an extension is required, we liaise with the prescribing clinical team before arranging continuation of the rental.
6. End of the clinical episode
When the patient’s temporary seating requirement ends, we coordinate recovery of the equipment with the relevant parties. This includes:
The end of the rental therefore forms part of the managed clinical pathway rather than being treated as a separate equipment transaction.
7. Decommissioning, infection control and fleet assurance
Returned equipment does not immediately re-enter clinical use. Every chair undergoes a controlled decommissioning and quality assurance process before it can be allocated to another patient. The process includes:
This provides a defined separation between patient episodes and ensures that equipment is appropriately inspected, cleaned and prepared before being made available for another clinical prescription.
8. Clinical sign off and outcome validation
At the conclusion of the clinical episode, outcome validation is completed through the PMS (Post Market Surveillance), incorporating feedback from the patient, family/carers and prescribing or responsible clinical team, as appropriate. The purpose of this stage is to confirm that the prescribed seating solution was implemented as intended and to establish how well it met the patient’s clinical, functional and day to day needs throughout the rental period. Outcome validation includes:
Feedback from the family/carers is an important component of outcome validation because they may observe the patient’s use, tolerance, comfort and functional response to the seating solution over an extended period and within the patient’s normal environment.
The prescribing or responsible clinical team provides the appropriate clinical review and sign-off, while patient and family/carer feedback contributes to the overall assessment of the effectiveness and suitability of the seating intervention.
The completed PMS record provides an auditable record of the prescription, implementation, patient/family experience and clinical outcome, providing a clear point of closure for the clinical episode. Where outcome validation identifies an unresolved clinical concern or a change in the patient’s requirements, this is referred back to the prescribing clinical team for appropriate clinical review before the episode is formally closed.
Clinical Governance and responsibilities
The service is based on a clear division of responsibilities:
| Clinical team | Managed clinical seating service |
|---|---|
| Establishes clinical need | Implements the prescribed seating specification |
| Provides the clinical prescription | Configures and prepares the equipment |
| Determines required clinical interventions | Performs technical and seating checks |
| Reviews significant changes in clinical need | Supports fitting and commissioning |
| Makes clinical decisions regarding changes to prescription | Provides patient/carer equipment education |
| Provides ongoing clinical insight where required | Provides technical and operational support |
| Determines when the clinical seating episode should end | Coordinates logistics, collection and equipment recovery |
This separation ensures that the service supports clinical decision making without replacing the prescribing role of the responsible clinical team.
What the clinical team is gaining
The managed clinical seating service is more than the short term provision of a chair. It provides an end to end managed pathway incorporating:
The clinical objective
The objective is to ensure that the patient has access to an appropriate, correctly configured and quality-assured seating solution at the point it is clinically required, with appropriate support throughout the period of use. For the clinical team, this provides a single managed service around the equipment element of the patient’s pathway – reducing operational and logistical burden while maintaining clear clinical responsibility and communication.
The value of the service is therefore not simply the provision of a chair. It is the managed clinical seating pathway surrounding that chair: from prescription and preparation, through fitting and ongoing support, to recovery, decontamination and controlled re-use.